The highlights: “...over a period of time whe
Post# of 11802
“...over a period of time where J&J sold billions and billions of dollars in value for their test strips, where in the companies' opinion, every one of those test strips sold infringed on our patents.''
Mr. Berman concluded, ''The expected new DECN products being launched into the market, with DECN on the cusp of new IP insurance, and with J&J's Lifescan division sale pending, the DECN infringement case is expected to conclude sooner than we had anticipated, and we believe sooner than J&J anticipated.''
DECN anticipates filing its 2017 Annual Report on or about March 31, 2018.